A Phase IV, Randomized, Observer-blind, Active-controlled, Single-Center Study to Evaluate Lot to Lot Consistency and Immunogenicity and Safety of an Inactivated TriValent Split Seasonal Influenza Virus Vaccine (TY flu) in Healthy Chinese Subjects Aged 3 Years and above

Trial Profile

A Phase IV, Randomized, Observer-blind, Active-controlled, Single-Center Study to Evaluate Lot to Lot Consistency and Immunogenicity and Safety of an Inactivated TriValent Split Seasonal Influenza Virus Vaccine (TY flu) in Healthy Chinese Subjects Aged 3 Years and above

Completed
Phase of Trial: Phase IV

Latest Information Update: 22 Apr 2016

At a glance

  • Drugs Influenza virus vaccine (Primary) ; TY 01 (Primary)
  • Indications Influenza virus infections
  • Focus Pharmacodynamics
  • Sponsors Zhejiang Tianyuan Bio-pharmaceutical
  • Most Recent Events

    • 07 Aug 2013 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top